OR7E22P

Across TCGA pan-cancer cohorts, OR7E22P RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated OR7E22P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher OR7E22P RNA is associated with better overall survival. In most high-consensus cancer types, elevated OR7E22P expression acts as an unfavorable survival marker, although some lineages such as UVM and CESC show a favorable association.

UVM, ACC, and KICH are the cancer types where OR7E22P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Median	All	0.807	0.399	<.001	106	view →
ACC	DFS	Median	All	0.378	0.706	<.001	92	view →
KICH	OS	Quartile	II,III,IV	0.467	0.953	<.001	72	view →
LIHC	OS	Tertile	II,III,IV	0.190	0.662	<.001	60	view →
COAD	DFS	Quartile	All	0.553	0.778	.002	39	view →
KIRP	OS	Quartile	III,IV	0.316	0.783	<.001	26	view →
CESC	DFS	Tertile	III,IV	0.899	0.437	.001	24	view →
LGG	OS	Tertile	All	0.946	0.805	.001	18	view →
BLCA	OS	Quartile	II,III,IV	0.600	0.363	.013	17	view →
OV	OS	Quartile	All	0.879	0.792	.001	16	view →
GBM	OS	Tertile	All	0.542	0.305	<.001	15	view →
KIRC	DFS	Quartile	IV	0.150	0.368	.012	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

OR7E22P–UVM (OS)

Open the UVM breakdown →